Startseite Kongressberichte & Archiv BCC2019 Session 3: Biology of breast cancer II: Prediction of response

Session 3: Biology of breast cancer II: Prediction of response

Chairs: Giuseppe Curigliano (Italy), C. Kent Osborne (USA)

  • Heterogeneity in treatment response in patients with HER2 positive breast cancer (Aleix Prat, Spain)
  • Heterogeneity in treatment response in patients with luminal breast cancer (Matthew Ellis, USA)
  • Heterogeneity in treatment response in patients with triple negative breast cancer (Carsten Denkert, Germany)
  • Identifying research priorities in prediction of response in patients with early breast cancer (Lisa Carey, USA)

BCC2019 PARTICIPANT: PASSWORD in BCC e-mail from March 23.